Protocol - Neuropathy - Autonomic Assessment - Adult
- Ataxia Rating Scale
- Diabetic Peripheral Neuropathy
- Disability Index
- Quality of Life - Adult
- Quality of Life - Pediatric
- Quality of Life Enjoyment and Satisfaction - Adult
- Quality of Life Enjoyment and Satisfaction - Children
Description
The Survey of Autonomic Symptoms (SAS) is a self-administered 12-item questionnaire that measures autonomic symptoms over the past 6 months in subjects with mild neuropathy. The severity of each item is rated on 5-point Likert scale (1 is least severe; 5 is most severe). The total number of symptoms is calculated as the sum of column A. The total impact score is calculated as the total of column B.
Specific Instructions
The External Review Panel notes that in comparison to the Michigan Neuropathy Screening Instrument (MNSI) included in the Diabetic Peripheral Neuropathy measure, the Survey of Autonomic Symptoms (SAS) is appropriate for assessing mild autonomic symptoms associated with all types of small-fiber neuropathies.
Availability
Protocol
Survey of Autonomic Symptoms | ||
| Q1a. Have you had any of the following health symptoms during the past 6 months? (1 _Yes; 0 _ No) | Q1b. If you answered yes in Q1a, how much would you say the symptom bothers you? (1 _ Not at all; 2 _ A little; 3 _ Some; 4 _ A moderate amount;5 _ A lot) |
Symptom/health problem | 1 0 | 1 2 3 4 5 |
1. Do you have lightheadedness? | 1 0 | 1 2 3 4 5 |
2. Do you have a dry mouth or dry eyes? | 1 0 | 1 2 3 4 5 |
3. Are your feet pale or blue? | 1 0 | 1 2 3 4 5 |
4. Are your feet colder than the rest of your body? | 1 0 | 1 2 3 4 5 |
5. Is sweating in your feet decreased compared to the rest of your body? | 1 0 | 1 2 3 4 5 |
6. Is sweating in your feet decreased or absent (for example, after exercise or during hot weather)? | 1 0 | 1 2 3 4 5 |
7. Is sweating in your hands increased compared to the rest of your body? | 1 0 | 1 2 3 4 5 |
8. Do you have nausea, vomiting, or bloating after eating a small meal? | 1 0 | 1 2 3 4 5 |
9. Do you have persistent diarrhea (more than 3 loose bowel movements per day)? | 1 0 | 1 2 3 4 5 |
10. Do you have persistent constipation (less than 1 bowel movement every other day)? | 1 0 | 1 2 3 4 5 |
11. Do you have leaking of urine? | 1 0 | 1 2 3 4 5 |
12. Do you have difficulty obtaining an erection (men)? | 1 0 | 1 2 3 4 5 |
Number of symptoms reported: _________ (sum of column A, 0-12 for men and 0-11 for women); total symptom impact score: _________ (sum of column B, 0-60 for men and 0-55 for women). |
Personnel and Training Required
None
Equipment Needs
None
Requirements
Requirement Category | Required |
---|---|
Major equipment | No |
Specialized training | No |
Specialized requirements for biospecimen collection | No |
Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult, Senior
Participants
Adult, aged 18 years and older.
Selection Rationale
The Survey of Autonomic Symptoms (SAS) was vetted against similar protocols and chosen because it is a relatively short, validated protocol that focuses more on autonomic symptoms that characterize small-fiber neuropathies.
Language
English
Standards
Standard | Name | ID | Source |
---|---|---|---|
Human Phenotype Ontology | Peripheral Neuropathy | HP:0009830 | HPO |
caDSR Form | PhenX PX130202 - Neuropathy Autonomic Assessment Adult | 6912158 | caDSR Form |
Derived Variables
None
Process and Review
Expert Review Panel 4 (ERP 4) reviewed the measures in the Neurology, Psychiatric, and Psychosocial domains.
Guidance from ERP 4 included the following:
- Changed name of measure
- Added new protocol
- Created new data dictionary
Protocol Name from Source
Survey of Autonomic Symptoms (SAS)
Source
Zilliox, L., Peltier, A. C., Wren, P. A., Anderson, A., Smith, A. G., Singleton, J. R., Feldman, E. L., Alexander, N. B., & Russell, J. W. (2011). Assessing autonomic dysfunction in early diabetic neuropathy: The Survey of Autonomic Symptoms. Neurology, 76(12), 1099-1105.
General References
Kim, S. H., Lee, K. A., Jin, H. Y., Baek, H. S., & Park, T. S. (2014). Relationship between the Korean Version Survey of the Autonomic Symptoms Score and cardiac autonomic neuropathy parameters in patients with diabetic peripheral neuropathy. Diabetes and Metabolism Journal, 38(5), 349-355.
Protocol ID
130202
Variables
Export VariablesVariable Name | Variable ID | Variable Description | dbGaP Mapping | |
---|---|---|---|---|
PX130202_Autonomic_Assessment_Adult_Difficulty_Obtaining_Erection | ||||
PX130202120100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Difficulty_Obtaining_Erection_Symptoms_Discomfort | ||||
PX130202120200 | If you answered yes in Q12a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Dry_Mouth_Dry_Eyes | ||||
PX130202020100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Dry_Mouth_Dry_Eyes_Symptoms_Discomfort | ||||
PX130202020200 | If you answered yes in Q2a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Feet_Colder | ||||
PX130202040100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Feet_Colder_Symptoms_Discomfort | ||||
PX130202040200 | If you answered yes in Q4a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Feet_Pale_Blue | ||||
PX130202030100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Feet_Pale_Blue_Symptoms_Discomfort | ||||
PX130202030200 | If you answered yes in Q3a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Leaking_Urine | ||||
PX130202110100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Leaking_Urine_Symptoms_Discomfort | ||||
PX130202110200 | If you answered yes in Q11a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Lightheadedness | ||||
PX130202010100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Lightheadedness_Symptoms_Discomfort | ||||
PX130202010200 | If you answered yes in Q1a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Nausea_Vomiting_Bloating_Small_Meal | ||||
PX130202080100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Nausea_Vomiting_Bloating_Small_Meal_Symptoms_Discomfort | ||||
PX130202080200 | If you answered yes in Q8a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Persistent_Constipation | ||||
PX130202100100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Persistent_Constipation_Symptoms_Discomfort | ||||
PX130202100200 | If you answered yes in Q10a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Persistent_Diarrhea | ||||
PX130202090100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Persistent_Diarrhea_Symptoms_Discomfort | ||||
PX130202090200 | If you answered yes in Q9a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Feet_Decreased | ||||
PX130202050100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Feet_Decreased_Absent | ||||
PX130202060100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Feet_Decreased_Absent_Symptoms_Discomfort | ||||
PX130202060200 | If you answered yes in Q6a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Feet_Decreased_Symptoms_Discomfort | ||||
PX130202050200 | If you answered yes in Q5a, how much would more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Hands_Increased | ||||
PX130202070100 | Have you had any of the following health more | N/A | ||
PX130202_Autonomic_Assessment_Adult_Sweating_Hands_Increased_Symptoms_Discomfort | ||||
PX130202070200 | If you answered yes in Q7a, how much would more | N/A |
Measure Name
Neuropathy
Release Date
November 28, 2017
Definition
A measure to assess neuropathy.
Purpose
This measure can be used to assess the severity of symptoms and disability associated with peripheral neuropathy caused by a number of disorders including tumors, infections, autoimmune diseases, and inherited disorders such as Charcot-Marie-Tooth disease.
Keywords
Neurology, small fiber neuropathy, diabetic neuropathy, clinical neuropathy assessment, autonomic neuropathy, gerontology, aging, geriatrics
Measure Protocols
Protocol ID | Protocol Name |
---|---|
130201 | Neuropathy - Clinical Assessment |
130202 | Neuropathy - Autonomic Assessment - Adult |
Publications
There are no publications listed for this protocol.